Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Parenting quality at age 3 predicts adolescent reward responsiveness

22

Jul 2026

Parenting quality at age 3 predicts adolescent reward responsiveness

In 465 young people followed from late childhood to late adolescence, EEG reward responses increased until mid-adolescence before declining by age 18. Higher positive parenting and lower negative parenting at age 3 predicted stronger developmental changes in neural responses to monetary rewards, while early stress exposure showed no significant association.

Red meat intake emerges as a potential pancreatic cancer risk factor

22

Jul 2026

Red meat intake emerges as a potential pancreatic cancer risk factor

A systematic review and meta-analysis of 16 studies involving nearly 2 million participants found that higher red meat intake was associated with a modestly higher risk of pancreatic cancer. Processed meat intake showed no statistically significant association, although variation between studies means a small effect cannot be excluded.

Frequent TV watching links to higher white matter lesion volume

22

Jul 2026

Frequent TV watching links to higher white matter lesion volume

ARIC researchers linked self-reported TV watching and occupational sitting in midlife with brain MRI measures obtained roughly 24 years later in 1,712 adults without dementia. Frequent TV watching was associated with greater white matter hyperintensity volume and lower volumes in several brain regions, while sitting at work was associated with lower white matter hyperintensity volume and larger selected cortical volumes.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.